Immunogenicity of recombinant vaccinia viruses expressing hepatitis B virus surface antigen in mice
✍ Scribed by Irina M. Grigorieva; Vitaly G. Grigoriev; Ludmila G. Zakharova; Galina V. Pashvykina; Vadim Y. Shevlyagin; Anatoly D. Altstein
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 349 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0165-2478
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Prostate-specific antigen (PSA) is a serine protease secreted by prostatic epithelial cells and is widely used as a marker for prostate cancer. The tissue specificity of PSA makes it a potential target for active specific immunotherapy, especially in prostate cancer patients who have undergone prost
## Abstract We previously showed that hepatitis B surface antigen (HBsAg)‐producing transgenic mice were more sensitive to hepatocarcinogens than their normal littermates were. We have now investigated the regulation of hepatitis B virus (HBV) gene expression in carcinogen‐induced liver tumors of H
Two types of recombinant vaccinia viruses (VVs) expressing the env gene of the human T-cell leukemia virus type I (HTLV-I) were reported previously. One recombinant VV, WR-proenv1, synthesized the authentic env protein. In the other recombinant VV, WR-env17, the env gene was inserted within the sign